Related Experiment Video

Updated: May 15, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Microarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin

Bo Peng1, Yixue Gu, Yan Xiong

  • 1Affiliated Cancer Hospital and Cancer Research Institute, Guangzhou Medical University, Guangzhou, Guangdong, China.

Plos One
|December 20, 2012
PubMed

Insights

TCRP1 gene confers cisplatin resistance in oral squamous cell carcinoma (OSCC). Targeting TCRP1 and metallothionein1X (MT1X) sensitizes OSCC cells to chemotherapy, offering potential for improved patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Resistance

Background:

  • TCRP1, a novel multidrug-resistance associated gene, was previously shown to mediate cisplatin resistance in oral squamous cell carcinoma (OSCC) cells.
  • The precise molecular mechanisms governing TCRP1's role in drug resistance require further investigation.

Purpose of the Study:

  • To elucidate the molecular mechanism by which TCRP1 mediates cisplatin resistance in OSCC.
  • To identify novel molecular interactions and signaling pathways involving TCRP1.

Main Methods:

  • Utilized Human Toxicology and Drug Resistance Microarray to identify differentially expressed genes.
  • Performed co-immunoprecipitation and GST-pull down assays to investigate protein interactions.
  • Employed siRNA-mediated knockdown of TCRP1 and MT1X to assess functional effects on cisplatin sensitivity.

Main Results:

  • Identified 30 genes with significantly altered expression in TCRP1 knockdown OSCC cells.
  • Confirmed physical interactions between TCRP1 and metallothionein1X (MT1X) as well as Akt.
  • Demonstrated that knockdown of TCRP1 and MT1X sensitizes OSCC cells to cisplatin, increasing apoptosis and inhibiting proliferation.
  • Indicated that TCRP1's function involves activation of the PI3K/Akt/NF-κB signaling pathway.

Conclusions:

  • TCRP1 plays a significant role in mediating cisplatin resistance in OSCC, potentially through the PI3K/Akt/NF-κB pathway.
  • TCRP1 and its interacting protein MT1X represent potential therapeutic targets for enhancing cisplatin efficacy in OSCC patients.
  • Targeting TCRP1 could improve treatment outcomes and survival rates for patients with oral squamous cell carcinoma.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...